Financial insights of AMED

MyFinsight

For the quarter ending 2025-06-30, AMED made $54,741K in revenue. $28,084K in net income. Net profit margin of 51.30%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Other	-	57,965	57,979	56,777
Impairment	-	-	12,098	-
Salaries and benefits	-	131,968	132,796	134,833
Depreciation and amortization	-	4,447	4,419	4,774
Miscellaneous, net	4,506	1,508	1,882	2,522
Cost of service, inclusive of depreciation	-	334,050	333,076	337,563
Interest income	3,016	2,873	2,354	2,017
Non-cash compensation	-	6,223	7,237	6,726
Interest expense	6,415	6,422	7,664	7,772
Merger-related expenses	-	16,769	19,034	16,669
Equity in earnings from equity method investments	1,641	1,794	1,431	1,891
Total operating expenses	-	551,422	578,736	557,342
Gain on equity method investment	0	48,093	-	-
Revenues	-	594,781	584,733	587,671
Total other income (expense), net	2,748	47,846	-1,998	-1,342
Operating income	45,578	43,359	5,998	30,329
Income before income taxes	48,326	91,205	4,000	28,987
Income tax expense	19,274	29,384	9,462	12,473
Net income	29,052	61,821	-5,462	16,514
Net income attributable to noncontrolling interests	968	809	-2,472	-397
Net income attributable to amedisys, inc	28,084	61,012	-2,990	16,911

Net income attributable to amedisys, inc. common stockholders	0.84	1.84	-0.09	0.51
Net income attributable to amedisys, inc. common stockholders	0.85	1.86	-0.095	0.52
Weighted average shares outstanding, basic (shares)	32,849,000	32,793,000	-16,366,500	32,745,000
Weighted average shares outstanding, diluted (shares)	33,289,000	33,218,000	-16,565,500	33,135,000